Clinical Trial Update: PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating PD-1 blockade combined with intensity-modulated radiation therapy for intermediate-risk nasopharyngeal carcinoma; current status is unk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Drugs mentioned

• PD-1 inhibitor (unspecified)

Snippet

Sponsor: XIANG YANQUN | Conditions: Nasopharyngeal Carcinoma, T2-3N0 or T1-2N1 | Phase 2 | Status: UNKNOWN